Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Opus Genetics (IRD) Other Operating Expenses (2020 - 2024)

Opus Genetics has reported Other Operating Expenses over the past 7 years, most recently at $28.0 million for Q4 2024.

  • Quarterly Other Operating Expenses changed N/A to $28.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $28.0 million through Sep 2025, changed N/A year-over-year, with the annual reading at $28.0 million for FY2024, N/A changed from the prior year.
  • Other Operating Expenses was $28.0 million for Q4 2024 at Opus Genetics, up from $8.4 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $28.0 million in Q4 2024 and troughed at $2.1 million in Q1 2020.